|
Market Closed -
NYSE
21:00:02 19/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 41.00 USD | +1.13% |
|
-4.56% | - |
| 11:35am | AstraZeneca and Oracle partner to advance AI in clinical trials | AN |
| 09:00am | AstraZeneca, Oracle Launch AI Collaboration to Advance Clinical Trial Results | MT |
| Market Cap | 393B 350B 324B 295B 553B 37,246B 563B 3,891B 1,530B 19,467B 1,474B 1,443B 62,231B | P/E 2027 * |
19.5x | P/E 2028 * | 14.2x |
|---|---|---|---|---|---|
| Enterprise Value | 510B 455B 421B 383B 718B 48,343B 730B 5,050B 1,986B 25,267B 1,913B 1,873B 80,772B | EV / Sales 2027 * |
5.64x | EV / Sales 2028 * | 4.1x |
| Free-Float |
61.6% | Yield 2027 * |
1.54% | Yield 2028 * | 1.6% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ORCL.PRD | Delayed | |
CBOE
| ORCL.PRD | Real-time |
Last Transcript: Oracle Corporation
| 1 day | +1.13% | ||
| 1 week | -4.56% | ||
| Current month | -7.32% | ||
| 1 month | -13.36% | ||
| 3 months | +0.59% | ||
| 6 months | -21.09% |
| 1 week | 40.28 |  | 43.6 |
| 1 month | 40.28 | | 48.5 |
| Current year | 37.79 | | 70.49 |
| 1 year | 37.79 | | 70.49 |
| 3 years | 37.79 | | 70.49 |
| 5 years | 37.79 | | 70.49 |
| 10 years | 37.79 | | 70.49 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Sicilia
CEO | Chief Executive Officer | 55 | 21/09/2025 |
Clayton Magouyrk
CEO | Chief Executive Officer | 40 | 21/09/2025 |
Larry Ellison
CEO | Chief Executive Officer | 71 | 15/06/1977 |
| Director | Title | Age | Since |
|---|---|---|---|
Larry Ellison
CHM | Chairman | 71 | 30/04/1995 |
Michael Boskin
BRD | Director/Board Member | 81 | 31/03/1994 |
Jeffrey Henley
CHM | Chairman | 81 | 31/12/2003 |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 90.42B 80.6B 74.67B 67.89B 127B 8,573B 129B 896B 352B 4,481B 339B 332B 14,324B | 132B 117B 109B 98.89B 186B 12,488B 189B 1,304B 513B 6,527B 494B 484B 20,864B |
| Net income | 20.4B 18.18B 16.84B 15.31B 28.74B 1,934B 29.21B 202B 79.44B 1,011B 76.53B 74.93B 3,231B | 29.03B 25.88B 23.97B 21.8B 40.9B 2,752B 41.57B 288B 113B 1,439B 109B 107B 4,599B |
| Net Debt | 117B 104B 96.65B 87.88B 165B 11,097B 168B 1,159B 456B 5,800B 439B 430B 18,541B | 147B 131B 122B 111B 208B 13,980B 211B 1,460B 574B 7,306B 553B 542B 23,357B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/10/26 | US$41.00 | +1.13% | 744,631 |
| 16/10/26 | US$40.54 | -4.39% | 707,767 |
| 15/10/26 | US$42.40 | +2.93% | 398,322 |
| 14/10/26 | US$41.20 | -6.46% | 341,408 |
| 13/10/26 | US$44.04 | +2.51% | 247,737 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ORCL Stock
- ORCL.PRD Stock
Select your edition
All financial news and data tailored to specific country editions
